Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Rule 8.3- Centaur Media Plc

23 Oct 2009 13:37

RNS Number : 3071B
BlackRock Group
23 October 2009
 



FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

 

1. KEY INFORMATION

Name of person dealing (Note 1)

BlackRock Group

Company dealt in

Centaur Media Plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

10p Ordinary

Date of dealing

22nd October 2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

7,380,493

5.24%

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

2,473,018

1.76%

Total

9,853,511

7.00%

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

(c) Rights to subscribe (Note 3)

 Class of relevant security:

Details

3. DEALINGS (Note 4)

 

(a) Purchases and sales 

Purchase/sale 

Number of securities

Price per unit (Note 5)

Purchase

14,298

GBP 0.5351

 

(b) Derivatives transactions (other than options) 

Product name, e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

CFD

Long

30,890

GBP 0.5359

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name e.g. call option 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price 

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5) 

 

 (ii) Exercising

 

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None……………………………………………………………………

Is a Supplemental Form 8 attached? (Note 9) NO

 

 

Date of disclosure

23rd October 2009

Contact name

Nicola Hylton

Telephone number

020 7743 2621

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETCKNKNBBDDAKB
Date   Source Headline
18th Apr 202311:47 amRNSDirector/PDMR Shareholding
12th Apr 20232:41 pmRNSDirector/PDMR Shareholding
4th Apr 20231:48 pmRNSAnnual Financial Report
21st Mar 20239:51 amRNSHolding(s) in Company
20th Mar 20233:33 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
20th Feb 20239:30 amRNSDirector/PDMR Shareholding
31st Jan 20239:01 amRNSHolding(s) in Company
23rd Jan 20239:25 amRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update & Declaration of a Special Dividend
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20222:19 pmRNSDirector/PDMR Shareholding
22nd Nov 20221:52 pmRNSDirector/PDMR Shareholding
16th Nov 20223:57 pmRNSDirector/PDMR Shareholding
24th Oct 20229:37 amRNSDirector/PDMR Shareholding
23rd Sep 202211:24 amRNSDirector/PDMR Shareholding
22nd Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 20225:13 pmRNSDirector/PDMR Shareholding
25th Jul 20229:50 amRNSDirector/PDMR Shareholding
20th Jul 20227:00 amRNSInterim Results
5th Jul 202210:30 amRNSDirector/PDMR Shareholding
23rd May 202210:33 amRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSNon-Executive Director Appointment
12th May 202211:08 amRNSDirector/PDMR Shareholding
11th May 20223:09 pmRNSResult of AGM
21st Apr 202211:27 amRNSDirector/PDMR Shareholding
1st Apr 202211:54 amRNSAnnual Financial Report
25th Mar 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20223:24 pmRNSDirector/PDMR Shareholding
18th Mar 20229:35 amRNSDirector/PDMR Shareholding
18th Mar 20229:31 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSPreliminary results
22nd Feb 20223:03 pmRNSDirector/PDMR Shareholding
20th Jan 202210:59 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSTrading Update
21st Dec 20214:31 pmRNSDirector/PDMR Shareholding
22nd Nov 202111:24 amRNSDirector/PDMR Shareholding
12th Nov 20219:54 amRNSHolding(s) in Company
12th Nov 20219:52 amRNSHolding(s) in Company
10th Nov 202110:11 amRNSNotification of major holdings
1st Nov 20214:18 pmRNSHolding(s) in Company
1st Nov 20211:46 pmRNSHolding(s) in Company
1st Nov 202110:37 amRNSHolding(s) in Company
1st Nov 202110:33 amRNSHolding(s) in Company
20th Oct 202111:54 amRNSDirector/PDMR Shareholding
13th Oct 20217:00 amRNSTrading Update
6th Oct 20219:30 amRNSHolding(s) in Company
21st Sep 202110:31 amRNSDirector/PDMR Shareholding
7th Sep 202112:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.